-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Shanghai Fosun Pharmaceutical (Group) Co.
, Ltd.
("Fosun Pharmaceutical" or "Group", stock code: 600196.
SH, 02196.
HK) announced that Fosun Pharmaceutical (Hong Kong) Co.
, Ltd.
TSMC (Buyer 1), Hon Hai and Yongling Foundation (Buyer 2), and Yuli Pharmaceuticals (a pharmaceutical company qualified for imported vaccines) formally signed the "Sales Agreement".
Fosun Industrial will provide TSMC, Hon Hai, and Yongling Foundation The entrusted Yuli Pharmaceuticals sells a total of 10 million doses of mRNA COVID-19 vaccines.
These vaccines will be donated by the buyer to the disease control agency in Taiwan for local vaccination
.
Wu Yifang, Chairman and CEO of Fosun Pharma said,
We are very pleased to see that this vaccine jointly developed by Fosun Pharma and BioNTech SE can play a positive role in the prevention and control of the epidemic in Taiwan.
We will work with our partners to make safe and effective vaccines available to Taiwan as soon as possible.
Maintain the life, health and safety of Taiwan compatriots and help Taiwan compatriots resume their normal lives as soon as possible
On March 16, 2020, Fosun Pharma and Bio-Entech jointly announced a strategic cooperation agreement.